159 related articles for article (PubMed ID: 37589643)
1. Sensing in Sacral Neuromodulation: A Feasibility Study in Subjects With Urinary Incontinence and Retention.
Goudelocke C; Jungbauer Nikolas LM; Bittner KC; Offutt SJ; Miller AE; Slopsema JP
Neuromodulation; 2024 Feb; 27(2):392-398. PubMed ID: 37589643
[TBL] [Abstract][Full Text] [Related]
2. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
Girtner F; Burger M; Mayr R
Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
[TBL] [Abstract][Full Text] [Related]
3. Optimal Lead Positioning in Sacral Neuromodulation: Which Factors Are Related to Treatment Outcome?
Jairam R; Marcelissen T; van Koeveringe G; van Kerrebroeck P
Neuromodulation; 2017 Dec; 20(8):830-835. PubMed ID: 28877395
[TBL] [Abstract][Full Text] [Related]
4. The Influence of Electrode Configuration Changes on the Sensory and Motor Response During (Re)Programming in Sacral Neuromodulation.
Tilborghs S; Van de Borne S; Vaganée D; De Win G; De Wachter S
Neuromodulation; 2022 Dec; 25(8):1173-1179. PubMed ID: 35088741
[TBL] [Abstract][Full Text] [Related]
5. Preliminary analysis of stimulation parameters for sacral neuromodulation in different indications: a multicenter retrospective cohort study from China.
Meng L; Yan Z; Wang X; Zhang Y; Zhu Z; Zhu W; Ling Q; Sun X; Gu Y; Lv J; Li Y
Int J Surg; 2024 Jun; 110(6):3536-3542. PubMed ID: 38445489
[TBL] [Abstract][Full Text] [Related]
6. Sacral neuromodulation for lower urinary tract dysfunction.
Van Kerrebroeck PE; Marcelissen TA
World J Urol; 2012 Aug; 30(4):445-50. PubMed ID: 21989816
[TBL] [Abstract][Full Text] [Related]
7. Outcomes in a contemporary cohort undergoing sacral neuromodulation using optimized lead placement technique.
Adelstein SA; Lee W; Gioia K; Moskowitz D; Stamnes K; Lucioni A; Kobashi KC; Lee UJ
Neurourol Urodyn; 2019 Aug; 38(6):1595-1601. PubMed ID: 31044466
[TBL] [Abstract][Full Text] [Related]
8. [Sacral neuromodulation in urology. The emperor's new clothes or effective high-tech medicine?].
Hoda MR; Fornara P
Urologe A; 2010 Oct; 49(10):1254-9. PubMed ID: 20859609
[TBL] [Abstract][Full Text] [Related]
9. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.
Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe MA; Elneil S
Neurourol Urodyn; 2019 Feb; 38(2):689-695. PubMed ID: 30592526
[TBL] [Abstract][Full Text] [Related]
10. Two-Staged Sacral Neuromodulation for the Treatment of Nonobstructive Urinary Retention: A Multicenter Study Assessing Predictors of Success.
Coolen RL; Groen J; Stillebroer AB; Scheepe JR; Witte LPW; Blok BFM
Neuromodulation; 2023 Dec; 26(8):1823-1830. PubMed ID: 35690510
[TBL] [Abstract][Full Text] [Related]
11. An overview of sacral neuromodulation: a treatment for patients with symptoms of lower urinary tract dysfunction.
Fletcher N
Br J Nurs; 2020 Aug; 29(15):848-856. PubMed ID: 32790556
[TBL] [Abstract][Full Text] [Related]
12. Pelvic Floor Muscle Electromyography as a Guiding Tool During Lead Placement and (Re)Programming in Sacral Neuromodulation Patients: Validity, Reliability, and Feasibility of the Technique.
Vaganée D; Van de Borne S; Voorham-van der Zalm P; Voorham J; Fransen E; De Wachter S
Neuromodulation; 2020 Dec; 23(8):1172-1179. PubMed ID: 32558094
[TBL] [Abstract][Full Text] [Related]
13. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects.
Tilborghs S; De Wachter S
Expert Rev Med Devices; 2022 Feb; 19(2):161-187. PubMed ID: 35061951
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sacral neuromodulation and percutaneous tibial nerve stimulation in the treatment of chronic nonobstructive urinary retention: A systematic review.
Ho FCS; He C; Yao HH; O'Connell HE; Gani J
Neurourol Urodyn; 2021 Jun; 40(5):1078-1088. PubMed ID: 33973670
[TBL] [Abstract][Full Text] [Related]
15. Sacral Neuromodulation: Standardized Electrode Placement Technique.
Matzel KE; Chartier-Kastler E; Knowles CH; Lehur PA; Muñoz-Duyos A; Ratto C; Rydningen MB; Sørensen M; van Kerrebroeck P; de Wachter S
Neuromodulation; 2017 Dec; 20(8):816-824. PubMed ID: 28975677
[TBL] [Abstract][Full Text] [Related]
16. Sacral neuromodulation using the standardized tined lead implantation technique with a curved vs a straight stylet: 2-year clinical outcomes and sensory responses to lead stimulation.
Vaganée D; Kessler TM; Van de Borne S; De Win G; De Wachter S
BJU Int; 2019 May; 123(5A):E7-E13. PubMed ID: 30537223
[TBL] [Abstract][Full Text] [Related]
17. The effect of sacral neuromodulation on pudendal nerve function and female sexual function.
Parnell BA; Howard JF; Geller EJ
Neurourol Urodyn; 2015 Jun; 34(5):456-60. PubMed ID: 24615871
[TBL] [Abstract][Full Text] [Related]
18. Prolonged percutaneous SNM testing does not cause infection-related explanation.
Amend B; Bedke J; Khalil M; Stenzl A; Sievert KD
BJU Int; 2013 Mar; 111(3):485-91. PubMed ID: 22738331
[TBL] [Abstract][Full Text] [Related]
19. Sacral Neuromodulation for Genitourinary Problems.
Banakhar M; Hassouna M
Prog Neurol Surg; 2015; 29():192-9. PubMed ID: 26394134
[TBL] [Abstract][Full Text] [Related]
20. Improving clinical outcomes for women with overactive bladder or urinary retention symptoms: a comparison of motor response voltages (1-9 V) during Stage 1 sacral neuromodulation.
Marinkovic SP; Ford JC
BJU Int; 2018 Sep; 122(3):472-479. PubMed ID: 29637712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]